arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Quanterix Corp

QTRX
$3.82 ▲ +0.06 (+1.60%) at close
Industrials ·Laboratory Analytical Instruments ·USLaboratory Analytical Instruments
10 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

Quanterix Corp faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $162.9M
Dividend Yield
Revenue Growth 1.1%
Op. Margin -90.4%
ROIC -40.5%
FCF / Share $-1.87
Trailing P/E
Price / Book 0.6x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 6, 2026.

10-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$138.90M
↑ +1.1%
Net Income Profit after all expenses
$-107.15M
↓ -178.1%
Operating Margin Operating profit as % of sales
-90.4%
↓ -136.1% 3th
FCF / Share Free cash flow per share
$-1.87
↓ -86.5%
Long-Term Debt Long-term obligations
$7.69M
↑ +0.9%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
3
Returns
20
Cash Quality
50

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 38 quarters